Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines

A marked antitumour efficacy is currently obtained by oxaliplatin (LOHP)–fluorouracil (FU)–folinic acid (FA) combination and by CPT11–FU–FA combination. Logically, the triple association LOHP, CPT11 and FUFA will be soon tested in cancer patients. The aim of the present study was to compare two sche...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischel, J-L, Rostagno, P, Formento, P, Dubreuil, A, Etienne, M-C, Milano, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363774/
https://www.ncbi.nlm.nih.gov/pubmed/11207057
http://dx.doi.org/10.1054/bjoc.2000.1600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363774/
https://www.ncbi.nlm.nih.gov/pubmed/11207057
http://dx.doi.org/10.1054/bjoc.2000.1600

Ejemplares similares